Clinical Trials Browser

Unknown × Non-squamous Non-small Cell Lung Cancer × Bevacizumab × Clear all

NCT02633189 2023-03-24

BEVERLY

Phase 3 Unknown

Non-squamous Non-small Cell Lung Cancer

NCT05394233 2022-05-27

Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC

Phase 2 Unknown

Non-squamous Non-small Cell Lung Cancer